A new Alzheimer’s treatment could cost Medicare billions of dollars by next year — well over Wall Street or even the drug’s manufacturer projections — according to a document obtained by STAT. 5.5 million people in the U.S. suffer from Alzheimer’s disease Declining general health is natural as one grows older. However, struggling with Alzheimer’s […] The post A New Alzheimer’s Treatment Could Cost Medicare Billions of Dollars by 2025 appeared first on Healthcare Weekly.
